Table 3.
List of antimicrobial drugs used and susceptibility percentages of 82 S. aureus isolates, stratified by MRSA and MSSA strain.
| Antimicrobial agents | Susceptibility profiles of S. aureus isolated |
|||
|---|---|---|---|---|
| MRSA (n = 31) |
MSSA (n = 51) |
|||
| Resistance n, (%) | Susceptible n, (%) | Resistance n, (%) | Susceptible n, (%) | |
| DN, Clindamycin (2μg) | 5 (16.1) | 26 (83.9) | 0 (0.0) | 51 (100.0) |
| E, Erythromycin (15μg) | 9 (29.1) | 22 (70.9) | 5 (9.8) | 46 (90.2) |
| CIP, Ciprofloxacin (5μg) | 16 (51.6) | 15 (48.4) | 6 (11.7) | 45 (88.3) |
| TE, Tetracycline (30 μg) | 20 (64.5) | 11 (35.5) | 28 (54.9) | 23 (55.1) |
| SXT, Trimethoprim-sulfamethoxazole (25 μg) | 26 (83.9) | 5 (16.1) | 28 (54.9) | 23 (55.1) |
| AMP, Ampicillin | - | - | 51 (100.0) | 0 (0.0) |
| PEN, Penicillin G | - | - | 51 (100.0) | 0 (0.0) |
| CN, Gentamicine | - | - | 8 (15.7) | 43 (84.3) |
| C, Chloramphenicol | - | - | 3 (5.9) | 48 (94.1) |
| CTX, Ceftriaxone | - | - | 2 (3.9) | 49 (96.1) |
All antimicrobial susceptibility breakpoints interpretation is according to British society for antimicrobial chemotherapy recommendation [13].